|
|
|
09.10.26 - 13:21
|
Deutschland will Pharma-Produktion in Afrika stärken (DPA-AFX)
|
|
|
BERLIN (dpa-AFX) - Deutschland will die lokale Produktion von Impfstoffen und Medikamenten in Afrika stärken. Zum Auftakt des Weltgesundheitsgipfels in Berlin sagte das Entwicklungsministerium weitere Unterstützung für einen Fonds ......
|
|
|
08.10.26 - 18:00
|
SpineGuard Announces Its Q3 Revenue (Business Wire)
|
|
|
A +22% increase in the total number of units sold during the period
Sales growing +25% outside the United States
A return to volume growth in the United States and confirmation of operational synergies with Omnia Medical
PARIS--(BUSINESS WIRE)--Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces its third quarter 2026 revenue.
Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated:
“The third quarter marks an important milestone for SpineGuard with a +22% increase in the number of units sold worldwide, driven by strong momentum in the various geographic regions where we operate through our commercial partners.
In the United States, unit sales are rising again, driven by orders from Omnia Medical, which are becoming more consistent and substantial. The commercial synergies we sought by transferring the assets o...
|
|
|
|
|
06.10.26 - 10:42
|
Ebola Spread Exhaust Healthcare Workers in Africa (Bloomberg)
|
|
|
20 weeks into the Ebola virus outbreak, health workers have managed to tamp down some of the early hotspot but the virus is still spreading in the Democratic Republic of Congo, putting experts under mounting pressure. Jennifer Zabasajja, Bloomberg's Chief Africa correspondent reports. (Source: Bloomberg)...
|
|
|
|
|
09.09.26 - 18:06
|
SpineGuard Reports 2026 Half-Year Results (Business Wire)
|
|
|
An interactive webinar will be held in French on Thursday, September 10, 2026, at 2:30 pm
Register HerePARIS--(BUSINESS WIRE)--Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces its financial results for the first half of the fiscal year ended June 30, 2026, as approved by the Board of Directors held on September 9, 2026.
Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated: “Our half-year financial results, which were down compared to the first half of 2025, are attributable to the recognition of all costs related to the sale of our U.S. subsidiary's assets to our partner Omnia Medical, the deferral of the proceeds from this sale through 2032, an inventory effect related to the transition, and a shift in business model. However, this in no way calls into question the soundness of this transaction or our g...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
